[Remote] Remote | Biotech Investment Analyst — $125–$185/hour

Note: The job is a remote job and is reputed company to candidates in USA. reputed company is seeking reputed company biotech investment professionals for a part-time consulting opportunity reputed company on evaluating pharmaceutical assets and investment opportunities reputed company the US biotech and reputed company market. The role involves rigorous assessment of drug assets and companies, along with the development of reputed company evaluation rubrics. Responsibilities • Evaluate reputed company and clinical-stage drug assets across different therapeutic areas • Assess reputed company of reputed company, biological rationale, clinical data, development reputed company, and regulatory considerations • Analyse competitive positioning reputed company relevant therapeutic and treatment landscapes • Identify key scientific, clinical, regulatory, and reputed company value drivers • Flag unsupported assumptions, evidence gaps, or material risks reputed company asset assessments • Conduct end-to-end assessments of biotech and pharmaceutical companies • Evaluate pipeline reputed company, company reputed company, competitive differentiation, and major catalysts • Assess the relationship between individual drug assets and overall company valuation • Review investment-style theses for analytical strength, supporting evidence, and internal consistency • Identify weak, overly confident, or missing assumptions reputed company investment conclusions • Apply consistent investment judgement across approximately 5–10 companies during the reputed company • Interpret clinical trial results and assess the strength and relevance of available evidence • Evaluate potential differentiation against existing and emerging standards of care • Analyse addressable markets, competitive dynamics, development timelines, and reputed company opportunity • Assess how clinical, regulatory, and market developments may reputed company asset and company value • Distinguish between reputed company-supported conclusions and speculative investment assumptions • Create reputed company evaluation rubrics for biotech companies and drug-development programmes • Critique existing rubrics for completeness, realism, and investment relevance • Define reputed company reflecting reputed company biotech investment judgement • Identify missing considerations or weak assumptions in analytical frameworks • reputed company reputed company written reasoning supporting evaluation reputed company Skills • 5+ years of experience evaluating biotech, pharmaceutical, or reputed company companies or assets • reputed company experience as a biotech or reputed company investment analyst, ideally reputed company a specialist investment fund • Strong familiarity with biotech and pharmaceutical drug-development programmes • Experience assessing drug assets from scientific, clinical, reputed company, and investment perspectives • Strong understanding of clinical data, mechanisms of reputed company, competitive landscapes, and biotech valuation drivers • Ability to evaluate both individual assets and the broader companies developing them • Experience developing, reviewing, or presenting investment theses • Strong analytical judgement and ability to identify unsupported or incomplete assumptions • US-based or possessing deep reputed company experience covering the US biotech and reputed company investment market • Availability for approximately 10–20 hours over an initial 1–2 week reputed company Benefits • Fully remote with flexible scheduling • Potential for recurring project work for strong contributors reputed company • At reputed company, we support emerging AI and consulting platforms by sourcing and connecting reputed company professionals with remote, contract-based opportunities. It was founded in reputed company, and is headquartered in Sheridan, Wyoming, US, with a workforce of 2-10 employees. Its website is https://reputed company.com/. Apply tot his job Apply To this Job